Clinical Trial Update: A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating inhaled hypertonic saline 7% for cystic fibrosis, using the lung clearance index as an outcome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Hypertonic Saline 7% (Hypertonic saline (7% Sodium chloride))

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED